)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Cyclezyme
Cyclezyme (CYCLE) investor relations material
Cyclezyme Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary28 Aug, 2026
Executive summary
Focused on developing enzymatic solutions for PET and polyamide recycling, with significant progress in industrial partnerships and technology optimization during H1 2026.
Successfully depolymerized industrial textile samples in collaboration with Albany International, demonstrating the potential for circular recycling.
Expanded enzyme platform to include nylon and polyamide, broadening market opportunities.
Strengthened financial position post-period with a directed share issue raising approximately 4.0 MSEK.
Financial highlights
Net sales were 0 KSEK for Q2 2026 (0 KSEK Q2 2025) and 0 KSEK for H1 2026 (150 KSEK H1 2025).
Operating loss was -735 KSEK for Q2 2026 (-671 KSEK Q2 2025) and -1,560 KSEK for H1 2026 (-1,018 KSEK H1 2025).
Net loss after tax was -743 KSEK for Q2 2026 (-682 KSEK Q2 2025) and -1,576 KSEK for H1 2026 (-1,041 KSEK H1 2025).
Cash flow for H1 2026 was -2,138 KSEK (1,084 KSEK H1 2025); cash and cash equivalents at period end were 445 KSEK (2,583 KSEK at 2025 year-end).
Equity at June 30, 2026, was 6,174 KSEK (7,750 KSEK at 2025 year-end).
Outlook and guidance
The recent share issue ensures sufficient funding for planned operations over the next 12 months.
Continued focus on scaling up technology, deepening industrial partnerships, and moving toward commercialization.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cyclezyme
- Losses increased as sales fell to zero, but a key patent and scaling projects mark strategic progress.CYCLE
Q1 2026 - Major project to scale enzymatic PET recycling advances, with stakeholder update on February 5.CYCLEInvestor update
- Revenue growth and reduced losses mark a pivotal year, with strong partner-driven project momentum.CYCLEQ4 2025
- Granted patent, industrial scale-up, and improved liquidity mark a pivotal growth phase.CYCLEQ3 2025
- Advanced toward commercialization with new patent, paid pilot, and strong liquidity.CYCLEQ2 2025
- Breakthrough in PET recycling technology and strong liquidity position despite ongoing losses.CYCLEQ3 2024
- Breakthrough in PET recycling achieved; losses widen but liquidity remains strong.CYCLEQ2 2024
- Cyclezyme advances commercialization with new partnerships, improved results, and solid funding.CYCLEQ1 2025
- No revenue but key breakthroughs and partnerships position Cyclezyme for EU-driven growth.CYCLEQ4 2024
Next Cyclezyme earnings date
Q3 202613 Nov, 2026
Cyclezyme
Next Cyclezyme earnings date
Q3 202613 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage